EndoShape has announced that it has received 510(k) marketing clearance for its Medusa vascular plug. The US Food and Drug Administration cleared the catheter-delivered device for arterial and venous embolization in the peripheral vasculature.
The device is based on EndoShape’s proprietary polymer material technology.
The Medusa vascular plug is deployed through a catheter placed in the patient’s bloodstream and occludes vessels in a single delivery sequence. Due to its non-metallic nature, the Plug produces minimal CT artifact.
A press release from EndoShape said that it would launch the device in the USA in early 2014.
